Misleading Measurements: Modeling the Effects of Blood Pressure Misclassification in a United States Population

Objective. The clinical diagnosis of hypertension is subject to misclassification, and this may be clinically important. This article calculates positive and negative predictive values for blood pressure measurement and assesses the frequency of clinically important blood pressure misclassification. Design, Setting, and Participants. A modeling study was carried out on 4763 adults in the National Health and Nutrition Examination Survey (NHANES) population. True treatment eligibility was determined by applying Joint National Committee (JNC) VII criteria to individuals in the study population. Each individual was also allocated a series of blood pressures incorporating an error term reflecting day-to-day measurement variation. Test positives are persons classified as needing treatment on the basis of the mean of 2 blood pressure measurements. Measurements and Main Results. Positive predictive values of a diagnosis of hypertension based on 2 measurements were calculated for each age-sex group. Low-risk false positives and highrisk false negatives were categorized as clinically important errors. Positive predictive values are high in persons older than age 65. In persons ages 16 to 34, the positive predictive value is 0.24 (95% confidence interval [CI]: 0.17–0.32) in men and 0.16 (95% CI: 0.06–0.26) in women. Persons younger than age 35 are almost always at low risk of cardiovascular disease, and therefore this misclassification is clinically important. Even with 24-hour ambulatory blood pressure measurement, positive predictive values in young adults are under 0.5. Conclusions. Blood pressure estimation is a poor diagnostic test in low-prevalence populations such as young adults. Estimation of blood pressure should be informed by prior estimation of cardiovascular risk.

[1]  F. Turnbull.  Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials , 2003, The Lancet.

[2]  P. Priest,et al.  Using thresholds based on risk of cardiovascular disease to target treatment for hypertension: modelling events averted and number treated , 2000, BMJ : British Medical Journal.

[3]  A. Tonkin,et al.  Lipid Management Guidelines -2001 , 2001 .

[4]  T. Marshall,et al.  Resource implications and health benefits of primary prevention strategies for cardiovascular disease in people aged 30 to 74: mathematical modelling study , 2002, BMJ : British Medical Journal.

[5]  H. Schouten,et al.  Is a series of blood pressure measurements by the general practitioner or the patient a reliable alternative to ambulatory blood pressure measurement? A study in general practice with reference to short-term and long-term between-visit variability. , 1997, American journal of hypertension.

[6]  Constance K Haan,et al.  Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women , 2004, Circulation.

[7]  A. Laupacis,et al.  When should hypertension be treated? The different perspectives of Canadian family physicians and patients. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[8]  K. Anderson,et al.  An updated coronary risk profile. A statement for health professionals. , 1991, Circulation.

[9]  D. Lewis,et al.  Who decides when to start preventive treatment? A questionnaire survey to compare the views of different population subgroups , 2003, Journal of epidemiology and community health.

[10]  J. Cutler,et al.  Effect of Antihypertensive Drug Treatment on Cardiovascular Outcomes in Women and Men , 1997, Annals of Internal Medicine.

[11]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[12]  B Rosner,et al.  Predictive values of routine blood pressure measurements in screening for hypertension. , 1983, American journal of epidemiology.

[13]  G. Brennan,et al.  Are preventive drugs preventive enough? A study of patients' expectation of benefit from preventive drugs. , 2002, Clinical medicine.

[14]  R. Reeves,et al.  The rational clinical examination. Does this patient have hypertension? How to measure blood pressure. , 1995, JAMA.

[15]  T. Marshall,et al.  A randomised controlled trial of the effect of anticipation of a blood test on blood pressure , 2002, Journal of Human Hypertension.

[16]  D. Mant,et al.  Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure , 2002, BMJ : British Medical Journal.

[17]  W. Bosch,et al.  De invloed van een rustperiode op de bloeddruk. , 1999 .

[18]  T. Pickering.  How should we take blood pressure in clinical practice?: The wider use of home and ambulatory monitoring should be encouraged , 2003, BMJ : British Medical Journal.

[19]  B. Morgenstern,et al.  Human blood pressure determination by sphygmomanometry. , 1993, Circulation.

[20]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. , 2004, European heart journal.